Brian Labadie

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Prostate Cancer

Basal Cell Carcinoma

Radical Prostatectomy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kiranj Chaudagar, Hanna M Hieromnimon, Anne Kelley, Brian Labadie, Jordan S Shafran, Srikrishnan Rameshbabu, Catherine Drovetsky, Kaela M Bynoe, Solanki Aniruddhsingh, Erica Markiewicz, Xiaobing Fan, Massimo Loda, Akash Patnaik
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan S Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela M Bynoe, Catherine Drovetsky, Solanki Aniruddhsingh, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan C Schürer, Alexander Swarbrick, David Brian Sykes, Akash Patnaik
Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Daniel J Olson, Zeynep Eroglu, Bruce E Brockstein, Andrew S Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario Velasco, Jose Lutzky, Emily F Higgs, Riyue Bao, Timothy Clifford Carll, Brian Labadie, Thomas Krausz, Yuanyuan Zha, Theodore Karrison, Vernon K Sondak, Thomas F Gajewski, Nikhil I Khushalani, Jason John Luke
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)